Abstract
VOLTAGE-DEPENDENT calcium channels mediate calcium entry into neurons, which is crucial for many processes in the brain including synaptic transmission, dendritic spiking, gene expression and cell death1–5. Many types of calcium channels exist in mam-malian brains6–19, but high-affinity blockers are available for only two types, L-type channels (targeted by nimodipine and other dihydropyridine channel blockers20–22) and N-type channels (targeted by ω-conotoxin22–26). In a search for new channel blockers, we have identified a peptide toxin from funnel web spider venom, ω-Aga-IVA, which is a potent inhibitor of both calcium entry into rat brain synaptosomes and of 'P-type' calcium channels8 in rat Purkinje neurons. ω-Aga-IVA will facilitate characterization of brain calcium channels resistant to existing channel blockers and may assist in the design of neuroprotective drugs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Llinas, R. & Yarom, Y. J. Physiol., Land. 315, 569–584 (1981).
Llinas, R. Science 242, 1654–1664 (1988).
Kuan, Y. F. & Schofield, C. N. Eur. J. Pharmac. 130, 273–278 (1986).
Sheng, M. & Greenberg, M. E. Neuron 4, 477–485 (1990).
Weiss, J. H., Hartley, D. M., Koh, J. & Choi, D. W. Science 247, 1474–1477 (1990).
Yaari, Y., Hamon, B. & Lux, H. D. Science 235, 680–682 (1987).
Takahashi, K., Wakamori, M. & Akaike, N. Neurosci. Lett. 104, 229–234 (1989).
Llinas, R. R., Sugimori, M., Lin, J. W. & Cherksey, B. Proc. natn. Acad. Sci. U.S.A. 86, 1689–1693 (1989).
Fisher, R. E., Gray, R. & Johnston, D. J. J. Neurosphysiol. 64, 91–104 (1990).
Bossu, J. L., Fagni, L. & Feltz, A. Pflügers Arch. 414, 92–94 (1989).
O'Dell, T. J., Alger, B. E. J. Physiol., Lond. 436, 739–767 (1991).
Snutch, T. P., Leonard, J. P., Gilbert, M. M., Lester, H. A. & Davidson, N. Proc. natn. Acad. Sci. U.S.A. 87, 3391–3395 (1990).
Starr, T. V. B., Prystay, W. & Snutch, T. P. Proc. natn. Acad. Sci. U.S.A. 88, 5621–5625 (1991).
Hui, A. et al. Neuron 7, 35–44 (1991).
Leonard, J. P., Nargeot, J., Snutch, T. P., Davidson, N. & Lester, H. A. J. Neurosci. 7, 875–881 (1987).
Mogul, D. J. & Fox, A. P. J. Physiol., Lond. 433, 259–281 (1991).
Mori, Y. et al. Nature 350, 398–402 (1991).
Regan, L. J., Sah, D. W. & Bean, B. P. Neuron 6, 259–280 (1991).
Regan, L. J. J. Neurosci. 11, 2259–2260 (1991).
Fox, A. P., Nowycky, M. C. & Tsien, R. W. J. Physiol., Lond. 394, 149 (1987).
Fox, A. P., Nowycky, M. C. & Tsien, R. W. J. Physiol., Lond. 394, 173 (1987).
Aosaki, T. & Kasai, H. Pflügers Arch. 414, 150 (1989).
Olivera, B. M., et al. Science 249, 257–263 (1990).
Olivera, B. M., et al. Science 230, 1338 (1985).
McCleskey, E. W., et al. Proc. natn. Acad. Sci. U.S.A. 84, 4327–4331 (1987).
Plummer, M. R., Logothetis, D. E. & Hess, P. Neuron 2, 1453 (1989).
Bindokas, V. P. & Adams, M. E. J. Neurobiol. 20, 171–188 (1989).
Adams, M. E., Bindokas, V. P., Hasegawa, L. & Venema, V. J. J. biol. chem. 265, 861–867 (1990).
Bindokas, V. P., Venema, V. J. & Adams, M. E. J. Neurophysiol. 66, 590–601 (1991).
Scott, R. H., Dolphin, A. C., Bindokas, V. P. & Adams, M. E. Molec. Pharmac. 38, 711–718 (1990).
Mintz, I. M., Venema, V. J., Adams, M. E. & Bean, B. P. Proc. natn. Acad. Sci. U.S.A. 88, 6628–6631 (1991).
Lin, J. W., Rudy, B. & Llinas, R. Proc. natn. Acad. Sci. U.S.A. 87, 4538–4542 (1990).
Adams, M. E., Herold, E. E. & Venema, V. J. J. comp. Physiol. 164, 333–342 (1989).
Quistad, G. B. et al. Biochem. biophys. Res. Commun. 169, 51–56 (1990).
Skinner, W. S. et al. J. biol. Chem. 264, 2150–2155 (1989).
Jasys, V. J., et al. J. Am. chem. Soc. 112, 6696–6704 (1990).
Scroggs, R. S. & Fox, A. P. J. Neurosci. 11, 1334–1346 (1991).
Dutar, P., Rascol, O. & Lamour, Y. Eur. J. Pharmac. 174, 261–266 (1989).
Feigenbaum, P., Garcia, M. L. & Kaczorowski, G. J. Biochem. biophys. Res. Commun. 154, 298–305 (1988).
Wagner, J. A., Snowman, A. M., Biswas, A., Olivera, B. M. & Snyder, S. H. J. Neurosci. 8, 3354–3359 (1988).
Suszkiw, J. B., Murawsky, M. M. & Shi, M. J. Neurochem. 52, 1260–1269 (1989).
Suszkiw, J. B., O'Leary, M. E., Murawsky, M. M. & Wang, T. J. Neurosci. 6, 1349–1357 (1986).
Lundy, P. M., Frew, R., Fuller, T. W. & Hamilton, M. G. Eur. J. Pharmac. 206, 61–68 (1991).
Reynolds, I. J. et al. Proc. natn. Acad. Sci. U.S.A. 83, 8804–8807 (1986).
Hillman, D. et al. Proc. natn. Acad. Sci. U.S.A. 88, 7076–7080 (1991).
Gornall, A. G., Bardawill, C. J. & David, M. M. J. biol. Chem. 177, 751–766 (1949).
Hamill, O. P., Marty, A., Neher, E., Sakmann, B. & Sigworth, F. J. Pflügers Arch. 391, 85–100 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mintz, I., Venema, V., Swiderek, K. et al. P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature 355, 827–829 (1992). https://doi.org/10.1038/355827a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/355827a0
This article is cited by
-
Structural basis for different ω-agatoxin IVA sensitivities of the P-type and Q-type Cav2.1 channels
Cell Research (2024)
-
Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations
Future Journal of Pharmaceutical Sciences (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.